Natural killer cell alterations correlate with loss of renal function and dialysis duration in uraemic patients

Nephrology Dialysis Transplantation

Volumn 23, Issue 4, 2008, Pages 1406-1414

  Vacher Coponat, Henri ^a   Brunet, Corinne ^a   Lyonnet, Luc ^a   Bonnet, Elodie ^a   Loundou, Andersen ^b   Sampol, José ^b,c   Moal, Valérie ^a   Dussol, Bertrand ^a,b   Brunet, Philippe ^a,b,c   Berland, Yvon ^a,b   Dignat George, Françoise ^a,b,c   Paul, Pascale ^a,c  

^a HÔPITAL DE LA CONCEPTION   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c INSERM   (France)

Author keywords

Cytotoxicity; End stage renal disease; Haemodialysis; Lymphocyte subsets; NK; Renal clearance

Indexed keywords

CD69 ANTIGEN; CD94 ANTIGEN; CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR4; INTERFERON; CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CHEMOKINE RECEPTOR; CX3CR1 PROTEIN, HUMAN; CXCR4 PROTEIN, HUMAN; IMMUNOGLOBULIN RECEPTOR; LEUKOCYTE ANTIGEN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; NCR2 PROTEIN, HUMAN; T LYMPHOCYTE ANTIGEN;

ADULT; ARTICLE; B LYMPHOCYTE; CELL COUNT; CELL FUNCTION; CONTROLLED STUDY; CYTOTOXICITY; DIALYSIS; FEMALE; HEMODIALYSIS; HUMAN; HUMAN CELL; KIDNEY CLEARANCE; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; UREMIA; BIOSYNTHESIS; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; COMPARATIVE STUDY; CYTOTOXICITY TEST; FLOW CYTOMETRY; FOLLOW UP; GLOMERULUS FILTRATION RATE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; METHODOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY; PROGNOSIS; RENAL REPLACEMENT THERAPY;

ANTIGENS, CD; ANTIGENS, CD19; ANTIGENS, CD3; ANTIGENS, CD4; ANTIGENS, CD94; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; B-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY TESTS, IMMUNOLOGIC; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; IMMUNITY, CELLULAR; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 1; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHENOTYPE; PROGNOSIS; RECEPTORS, CHEMOKINE; RECEPTORS, CXCR4; RECEPTORS, IMMUNOLOGIC; RENAL DIALYSIS; UREMIA;

EID: 42949147756     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm596     Document Type: Article

References (33)

1. Reddan DN, Klassen PS, Szczech LA et al. White blood cells as a novel mortality predictor in haemodialysis patients. Nephrol Dial Transplant 2003; 18: 1167-1173
2. Causes of death. United States Renal Data System. Am J Kidney Dis 1998; 32: S81-S88
3. Maisonneuve P, Agodoa L, Gellert R et al. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 1999; 354: 93-99
4. Fabrizi F, Dixit V, Magnini M, Elli A, Martin P. Meta-analysis: intradermal vs. intramuscular vaccination against hepatitis B virus in patients with chronic kidney disease. Aliment Pharmacol Ther 2006; 24: 497-506
5. Hou S. Pregnancy in chronic renal insufficiency and end-stage renal disease. Am J Kidney Dis 1999; 33: 235-252
6. Whitman SC, Ramsamy TA. Participatory role of natural killer and natural killer T cells in atherosclerosis: lessons learned from in vivo mouse studies. Can J Physiol Pharmacol 2006; 84: 67-75
7. Lodoen MB, Lanier LL. Natural killer cells as an initial defense against pathogens. Curr Opin Immunol 2006; 18: 391-398
8. Young NT. Immunobiology of natural killer lymphocytes in transplantation. Transplantation 2004; 78: 1-6
9. Hanna J, Goldman-Wohl D, Hamani Y et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med 2006; 12: 1065-1074
10. Nitta K, Akiba T, Kawashima A et al. Characterization of TH1/TH2 profile in uremic patients. Nephron 2002; 91: 492-495
11. Baj Z, Pokoca L, Majewska E, Luciak M, Tchorzewski H. T lymphocyte subsets and NK cell cytotoxicity in chronic hemodialysis patients. The effect of recombinant human erythropoietin (rHu-EPO) treatment. Arch Immunol Ther Exp (Warsz) 1992; 40: 201-206
12. Deenitchina SS, Ando T, Okuda S et al. Cellular immunity in hemodialysis patients: a quantitative analysis of immune cell subsets by flow cytometry. Am J Nephrol 1995; 15: 57-65
13. Griveas I, Visvardis G, Fleva A et al. Comparative analysis of immunophenotypic abnormalities in cellular immunity of uremic patients undergoing either hemodialysis or continuous ambulatory peritoneal dialysis. Ren Fail 2005; 27: 279-282
14. Pascal V, Schleinitz N, Brunet C et al. Comparative analysis of NK cell subset distribution in normal and lymphoproliferative disease of granular lymphocyte conditions. Eur J Immunol 2004; 34: 2930-2940
15. Stewart CA, Vivier E, Colonna M. Strategies of natural killer cell recognition and signaling. Curr Top Microbiol Immunol 2006; 298: 1-21
16. Moretta L, Ferlazzo G, Bottino C et al. Effector and regulatory events during natural killerdendritic cell interactions. Immunol Rev 2006; 214: 219-228
17. Charpentier B, Lang P, Martin B et al. Depressed polymorphonuclear leukocyte functions associated with normal cytotoxic functions of T and natural killer cells during chronic hemodialysis. Clin Nephrol 1983; 19: 288-294
18. Zaoui P, Hakim RM. Natural killer-cell function in hemodialysis patients: effect of the dialysis membrane. Kidney Int 1993; 43: 1298-1305
19. Cala S, Mazuran R, Kordic D. Negative effect of uraemia and cuprophane haemodialysis on natural killer cells. Nephrol Dial Transplant 1990; 5: 437-440
20. Gascon A, Orfao A, Lerma JL et al. Antigen phenotype and cytotoxic activity of natural killer cells in hemodialysis patients. Am J Kidney Dis 1996; 27: 373-379
21. Tanaka T, Porter CM, Horvath-Arcidiacono JA, Bloom ET. Lipophilic statins suppress cytotoxicity by freshly isolated natural killer cells through modulation of granule exocytosis. Int Immunol 2007; 19: 163-173
22. Ravet S, Scott-Algara D, Bonnet E et al. Distinctive NK cell receptor repertoires sustain highlevel constitutive NK cell activation in HIV-exposed uninfected individuals. Blood 2007.
23. Fernandez-Fresnedo G, Ramos MA, Gonzalez-Pardo MC et al. B lymphopenia in uremia is related to an accelerated in vitro apoptosis and dysregulation of Bcl-2. Nephrol Dial Transplant 2000; 15: 502-510
24. Matsumoto Y, Shinzato T, Takai I et al. Peripheral deletion of gamma-delta T cells in haemodialysis patients. Nephrol Dial Transplant 1998; 13: 2861-2866
25. Mocchegiani E, Malavolta M. NK and NKT cell functions in immunosenescence. Aging Cell 2004; 3: 177-184
26. Chow SC, Shao J, Wang H. Sample Size, Calculations in Clinical Research 2003, Marcel Dekker: New York, USA
27. Asaka M, Iida H, Izumino K, Sasayama S. Depressed natural killer cell activity in uremia. Evidence for immunosuppressive factor in uremic sera. Nephron 1988; 49: 291-295
28. Hayakawa M, Hatano T, Sunabe T, Higa I, Osawa A. Cytokine production and cytotoxicity of lymphocytes in patients on maintenance short- or long-term haemodialysis. Nephrol Dial Transplant 1994; 9: 655-661
29. Borrego F, Robertson MJ, Ritz J, Pena J, Solana R. CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor. Immunology 1999; 97: 159-165
30. Zingoni A, Palmieri G, Morrone S et al. CD69-triggered ERK activation and functions are negatively regulated by CD94/NKG2-A inhibitory receptor. Eur J Immunol 2000; 30: 644-651
31. Meier P, Dayer E, Blanc E, Wauters JP. Early T cell activation correlates with expression of apoptosis markers in patients with end-stage renal disease. J Am Soc Nephrol 2002; 13: 204-212
32. Robertson MJ. Role of chemokines in the biology of natural killer cells. J Leukoc Biol 2002; 71: 173-183
33. Cockwell P, Chakravorty SJ, Girdlestone J, Savage CO. Fractalkine expression in human renal inflammation. J Pathol 2002; 196: 85-90